OncoCyte Reports Successful Results of Lung Cancer Diagnostic Test Study; Targets 2017 Product Launch to Address ...
GlobeNewswire (press release) ALAMEDA, Calif., March 06, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests to aid in the early detection of cancer, today reported the successful completion of a critical step in the ... |
from Health - Google News http://ift.tt/2mWHgly
EmoticonEmoticon